Dysport® for the treatment of myofascial back pain: Results from an open-label, Phase II, randomized, multicenter, dose-ranging study
Keywords: ANOVA; analysis of variance; BoNT-A; botulinum toxin type A; ITT; intent-to-treat; LOCF; last observation carried forward; NSAIDs; non-steroidal anti-inflammatory drugs; PDI; Pain Disability Index; PP; per protocol; SD; standard deviation; Myofascial pain